Hormonal replacement therapy is necessary to assure a normal menstrual cycle and secondary sex characteristics and to reduce the risks of osteopenia, which suggests the importance of SRY in normal bone development and hormonal status61–63. The gene discussed is SRY; the disease is Osteopenia.